Comparative analysis evaluates banana lectins' structural and functional properties, suggesting biotechnological potential.
In this study, we conducted structural and comparative analyses of two recombinant banana lectins, rBanLec-like and H84T-BanLec, using both in silico and in vitro approaches. Sequence alignment showed 91.5% identity between the lectins, with differences in 12 amino acids. Structural modeling and secondary structure analysis indicated a high degree of structural similarity, with a root mean square deviation (RMSD) of 0.382 Å, suggesting that the sequence modifications did not lead to significant structural changes. Molecular docking experiments demonstrated a strong affinity of both lectins for mannose, with rBanLec-like exhibiting a lower binding free energy (− 6.6 kcal/mol) compared to H84T-BanLec (− 4.5 kcal/mol). Molecular dynamics simulations confirmed the stability of both proteins, although rBanLec-like displayed greater conformational flexibility. Expression in Escherichia coli showed successful production of both lectins, but rBanLec-like was detected in both soluble and insoluble fractions, whereas H84T-BanLec was exclusively obtained in the soluble fraction. Both lectins significantly inhibited the growth of colorectal adenocarcinoma cells by 62.6% and 76%, respectively. These findings contribute to the structural and functional understanding of banana lectins, highlighting their potential for biotechnological and therapeutic applications.
No takes yet. Share an insight, caveat, or question.
Sousa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: